Prothena to Participate in Jefferies 2023 Healthcare Conference
02 Junho 2023 - 5:05PM
Business Wire
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical
biotechnology company with a robust pipeline of investigational
therapeutics built on protein dysregulation expertise, today
announced that members of its senior management team will
participate in a fireside chat at the Jefferies Healthcare
Conference on Thursday, June 8, 2023, at 1:00 pm ET.
A live webcast of the fireside chat can be accessed through the
investor relations section of the Company's website at
www.prothena.com. Following the live presentation, a replay of the
webcast will be available on the Company's website for at least 90
days following the presentation date.
About Prothena
Prothena Corporation plc is a late-stage clinical biotechnology
company with expertise in protein dysregulation and a pipeline of
investigational therapeutics with the potential to change the
course of devastating neurodegenerative and rare peripheral amyloid
diseases. Fueled by its deep scientific expertise built over
decades of research, Prothena is advancing a pipeline of
therapeutic candidates for a number of indications and novel
targets for which its ability to integrate scientific insights
around neurological dysfunction and the biology of misfolded
proteins can be leveraged. Prothena’s pipeline includes both
wholly-owned and partnered programs being developed for the
potential treatment of diseases including AL amyloidosis, ATTR
amyloidosis, Alzheimer’s disease, Parkinson’s disease and a number
of other neurodegenerative diseases. For more information, please
visit the Company’s website at www.prothena.com and follow the
Company on Twitter @ProthenaCorp.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230531005915/en/
Investor and Media Contacts:
Investors IR@prothena.com
Media Michael Bachner, Senior Director, Corporate Communications
609-664-7308, michael.bachner@prothena.com
Prothena (NASDAQ:PRTA)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Prothena (NASDAQ:PRTA)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024